Clinical Trials Browser

Active not recruiting × gallium Ga 68 dotatate × Endocrine × Clear all

NCT06379217 2026-03-11

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Phase 1 Active not recruiting

EndocrineGenitourinary

Metastatic Neuroendocrine Prostate Cancer

NCT04069299 2025-12-05

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

Active not recruiting

Carcinoma, Neuroendocrine